By Josh White
Date: Monday 20 May 2024
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health launched a proposed $100m tender offer on Monday, aiming to repurchase shares at a fixed price of 250p each, or £25.00 per American depositary share (ADS).
By Iain Gilbert
Date: Thursday 25 Apr 2024
(Sharecast News) - Biotechnology company Puretech Health said on Thursday that 2023 had been "a landmark year" for the group, making "strong strategic and clinical progress".
By Benjamin Chiou
Date: Tuesday 09 Apr 2024
(Sharecast News) - Clinical-stage biotherapeutics group PureTech has announced that its founding chief executive is to step down to lead SeaPort Therapeutics, a PureTech company she founded that has just raised $100m in Series A financing.
Currency | UK Pounds |
Share Price | 178.00p |
Change Today | 4.80p |
% Change | 2.77 % |
52 Week High | 237.50p |
52 Week Low | 140.40p |
Volume | 311,512 |
Shares Issued | 270.81m |
Market Cap | £482.05m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:35 | 168,571 @ 178.00p |
16:35 | 343 @ 178.00p |
16:35 | 192 @ 178.00p |
16:35 | 910 @ 178.00p |
16:35 | 303 @ 178.00p |
Chair | Raju Kucherlapati |
CEO | Bharatt Chowrira |
You are here: research